Healthcare provider profile · identity verified

James M Mcintosh, MD

Family Practice · TOPEKA, KS · NPI 1093125320

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	450	107
Atorvastatin Calcium	Atorvastatin Calcium	447	121
Amlodipine Besylate	Amlodipine Besylate	290	77
Losartan Potassium	Losartan Potassium	273	75
Lisinopril	Lisinopril	225	66
Gabapentin	Gabapentin	217	48
Omeprazole	Omeprazole	212	56
Simvastatin	Simvastatin	185	47
Pantoprazole Sodium	Pantoprazole Sodium	182	53
Tamsulosin Hcl	Tamsulosin Hcl	175	49
Rosuvastatin Calcium	Rosuvastatin Calcium	170	51
Hydrochlorothiazide	Hydrochlorothiazide	154	45
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	124	26
Metoprolol Succinate	Metoprolol Succinate	112	26
Sertraline Hcl	Sertraline Hcl	98	23
Pravastatin Sodium	Pravastatin Sodium	94	25
Escitalopram Oxalate	Escitalopram Oxalate	87	27
Metformin Hcl Er	Metformin Hcl	87	26
Montelukast Sodium	Montelukast Sodium	86	24
Duloxetine Hcl	Duloxetine Hcl	85	27
Allopurinol	Allopurinol	84	24
Clonazepam	Clonazepam	84	14
Zolpidem Tartrate	Zolpidem Tartrate	83	17
Metoprolol Tartrate	Metoprolol Tartrate	81	22
Tizanidine Hcl	Tizanidine Hcl	77	28
Trazodone Hcl	Trazodone Hcl	75	22
Eliquis	Apixaban	74	13
Alprazolam	Alprazolam	71	12
Metformin Hcl	Metformin Hcl	71	20
Albuterol Sulfate Hfa	Albuterol Sulfate	70	28
Furosemide	Furosemide	68	18
Ropinirole Hcl	Ropinirole Hcl	67	suppressed
Carvedilol	Carvedilol	64	12
Clopidogrel	Clopidogrel Bisulfate	58	14
Alendronate Sodium	Alendronate Sodium	57	22
Bupropion Xl	Bupropion Hcl	56	18
Finasteride	Finasteride	56	15
Tramadol Hcl	Tramadol Hcl	56	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	16
Glimepiride	Glimepiride	51	11
Fluoxetine Hcl	Fluoxetine Hcl	50	14
Fluticasone Propionate	Fluticasone Propionate	47	23
Lorazepam	Lorazepam	47	13
Esomeprazole Magnesium	Esomeprazole Magnesium	46	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	14
Potassium Chloride	Potassium Chloride	43	13
Triamcinolone Acetonide	Triamcinolone Acetonide	42	12
Meloxicam	Meloxicam	41	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	12
Prednisone	Prednisone	37	15
Celecoxib	Celecoxib	36	13
Diclofenac Sodium	Diclofenac Sodium	36	11
Donepezil Hcl	Donepezil Hcl	36	suppressed
Ozempic	Semaglutide	33	suppressed
Cefdinir	Cefdinir	31	27
Pregabalin	Pregabalin	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Glipizide	Glipizide	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	11
Synthroid	Levothyroxine Sodium	28	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Ondansetron Odt	Ondansetron	27	suppressed
Famotidine	Famotidine	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Primidone	Primidone	26	suppressed
Divalproex Sodium Er	Divalproex Sodium	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Raloxifene Hcl	Raloxifene Hcl	23	suppressed
Spironolactone	Spironolactone	22	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Valsartan	Valsartan	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Atenolol	Atenolol	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Estradiol	Estradiol	17	suppressed
Gemtesa	Vibegron	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Linzess	Linaclotide	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Diazepam	Diazepam	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Westab Plus	Pnv,calcium 72/Iron/Folic Acid	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Aimovig Autoinjector	Erenumab-Aooe	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error